This is a Blanket Purchase Agreement (BPA) awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The BPA is for the provision of HP CT/NG DNA tests on a cost-per-test basis, with a potential value of $159,038.54 and a completion date of September 30, 2019. The contract is not set-aside and was awarded on...
This is a Blanket Purchase Agreement (BPA) awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Roche Diagnostics Corporation (Roche Diagnostics), a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for HP CT/NG DNA tests, priced on a cost-per-test basis, and is a renewal of an existing General Services Administration (GSA) Federal Supply Schedule (FSS) contract. The BPA...
This federal contract award is a Blanket Purchase Agreement (BPA) between the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 12 and Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp. The BPA is for the provision of HP CT/NG DNA tests on a cost-per-test basis, under the General Services Administration (GSA) Critical Analyzers, Laboratory schedule. The contract has a potential value of $146,686.34, a completion date of...
The Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) call order worth $299,999.03 to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, to provide reagents and consumables for HPV/CT/NG testing. This award is under Roche's existing GSA Schedule contract for critical laboratory analyzers and supplies. Roche, a foreign-owned manufacturer of in vitro diagnostics and medical devices, has a long history of providing equipment, reagents, and...
This is a Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics and laboratory equipment. The contract has a potential value of $106,654.42 and is for infectious disease molecular pathology testing services for the VA's VISN 22 network. The contract is a Firm Fixed Price arrangement without any set-aside designation. Roche Diagnostics...
This is a federal contract award made by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation to provide HPV/CT/NG DNA testing services. The contract is a Blanket Purchase Agreement (BPA) call under Roche's existing General Services Administration (GSA) schedule contract for critical laboratory analyzers and supplies. The award has a ceiling value of $168,719.59 and was made on September 30, 2015, with a completion date of February 17, 2017. The contract does not have a...
The Department of Veterans Affairs Veterans Health Administration has awarded a Blanket Purchase Agreement (BPA) to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, for infectious disease molecular pathology testing services. The contract has a potential value of $524,597.82 and a completion date of November 13, 2024. This BPA will allow VA hospitals within the Veterans Integrated Service Network 22 to acquire chemistry and immunochemistry laboratory testing capabilities,...
This is a Blanket Purchase Agreement (BPA) contract awarded by the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, valued at a ceiling of $732,611.92, is for the provision of automated chemical laboratory testing services, including reagents, test kits, and associated equipment and supplies. The contract does not have a set-aside...
This is a Blanket Purchase Agreement (BPA) awarded by the Veterans Integrated Service Network 22 (VISN 22) of the Department of Veterans Affairs to Roche Diagnostics Corporation for infectious disease molecular pathology testing on a cost-per-test basis. The contract has a ceiling value of $1,743,266.60 and a performance period ending on October 11, 2024. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, will provide the VA with chemistry and immunochemistry laboratory...
This federal contract award was made by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $275,705.32 Blanket Purchase Agreement (BPA) call order was issued under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration (GSA) Schedule contract, and is for the...